ICO — Iconovo AB Share News
0.000.00%
- SEK104.83m
- SEK66.64m
- SEK1.10m
Brief: Iconovo AB - Q2 Operating Loss Sek 6.6 Million
Brief: Iconovo Gets Order From ISR Regarding Nasal COVID-19 Vaccine
Brief: Iconovo Board Member And Largest Owner Buys Shares For Sek 380,000
Brief: Iconovo Completes Share Issue Of SEK 75 Mln
Brief: Iconovo Sets 5-Year Target Of Sek 200 Mln In Revenue
Brief: Iconovo Board Member Mats Johansson Buys 10,000 Shares In Co
Brief: Iconovo Sets Financial Targets For 2026
Brief: Iconovo And Respiratorius Sign Agreement For Development Of Inhalation Product To Treat Copd
Brief: Iconovo Extends Agreement With Amneal
Brief: Iconovo Extends Agreement With Amneal For Generic Symbicort
Brief: Iconovo Q1 Operating Loss Widens To SEK 7.3 Million
Brief: Iconovo: First Granted Icoone Patent In The United States
Brief: Iconovo Signs Agreement With ISR For Development Of Inhaled COVID-19 Vaccine
Brief: First Granted ICOone Patent In India
Brief: Iconovo: CEO Johan Wäborg Buys Shares For Sek 1,100,000
Brief: Iconovo Q4 Operating Loss Narrows To SEK 3.6 Million
Brief: Iconovo To Get Patent In US On Inhalation Device Icores
Brief: Iconovo Announces Target To Enter Into Two Customer Agreements In 2021
Brief: Iconovo Signs Agreement For Development Of Inhaled Oxytocin In ICOone For Maternal Health